Premium
Molecular markers for breast cancer diagnosis, prognosis and targeted therapy
Author(s) -
Lang Julie E.,
Wecsler Julie S.,
Press Michael F.,
Tripathy Debasish
Publication year - 2015
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23732
Subject(s) - medicine , breast cancer , targeted therapy , standard of care , precision medicine , cancer , oncology , intensive care medicine , cancer therapy , medical physics , pathology
Precision medicine involves understanding the molecular drivers unique to an individual patient's cancer so that specific factors may be targeted with the goal of improved patient outcomes. The purpose of this article is to review standard of care and research grade (non‐standard of care) biomarkers in breast cancer that may be useful for diagnosis, prognosis and targeted therapy. J. Surg. Oncol. 2015 111:81–90 . © 2014 Wiley Periodicals, Inc.